The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
amunix operating | 313 |
amunix | 26 |
biogen idec ma | 25 |
biogen ma | 11 |
eli lilly & company | 6 |
bioverativ therapeutics | 4 |
amunix operationg | 3 |
amunix operting | 1 |
amunix operation | 1 |
amunix | 9 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
extended recombinant polypeptides and compositions comprising same | 60 | 2009 |
growth hormone polypeptides and methods of making and using same | 42 | 2009 |
coagulation factor ix compositions and methods of making and using same | 34 | 2009 |
xten conjugate compositions and methods of making same | 32 | 2012 |
factor viii complex with xten and von willebrand factor protein, and uses thereof | 30 | 2012 |
unstructured recombinant polymers and uses thereof | 28 | 2006 |
factor viii compositions and methods of making and using same | 27 | 2012 |
treatment of pediatric growth hormone deficiency with human growth hormone analogues | 19 | 2013 |
glucagon-like peptide-2 compositions and methods of making and using same | 19 | 2011 |
glucose-regulating polypeptides and methods of making and using same | 18 | 2009 |